BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23656850)

  • 1. Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.
    Rodebaugh TL; Lenze EJ
    J Clin Psychiatry; 2013 Apr; 74(4):415-6. PubMed ID: 23656850
    [No Abstract]   [Full Text] [Related]  

  • 2. Facilitation of fear extinction by D-cycloserine: theoretical and clinical implications.
    Richardson R; Ledgerwood L; Cranney J
    Learn Mem; 2004; 11(5):510-6. PubMed ID: 15466301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure therapy, D-cycloserine, and functional magnetic resonance imaging in patients with snake phobia: a randomized pilot study.
    Nave AM; Tolin DF; Stevens MC
    J Clin Psychiatry; 2012 Sep; 73(9):1179-86. PubMed ID: 23059145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of Psychosocial Treatment With D-Cycloserine: Models, Moderators, and Future Directions.
    Otto MW; Kredlow MA; Smits JAJ; Hofmann SG; Tolin DF; de Kleine RA; van Minnen A; Evins AE; Pollack MH
    Biol Psychiatry; 2016 Aug; 80(4):274-283. PubMed ID: 26520240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.
    Hofmann SG
    Depress Anxiety; 2014 Mar; 31(3):175-7. PubMed ID: 24677604
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
    Krystal JH
    Biol Psychiatry; 2012 Jun; 71(11):932-4. PubMed ID: 22579302
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescriptive variables for d-cycloserine augmentation of exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Smits JA; Broekman TG; van Minnen A
    J Psychiatr Res; 2014 Jan; 48(1):40-6. PubMed ID: 24183818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
    Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
    J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
    Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
    Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
    Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
    Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-cycloserine augmentation of cognitive behavioral therapy for anxiety disorders: an update.
    Hofmann SG; Otto MW; Pollack MH; Smits JA
    Curr Psychiatry Rep; 2015 Jan; 17(1):532. PubMed ID: 25413638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-cycloserine augmentation for behavioral therapy.
    Shim SS; Hammonds MD; Vrabel MM
    Am J Psychiatry; 2008 Aug; 165(8):1050. PubMed ID: 18676606
    [No Abstract]   [Full Text] [Related]  

  • 18. Extinction learning as a moderator of d-cycloserine efficacy for enhancing exposure therapy in posttraumatic stress disorder.
    de Kleine RA; Smits JA; Hendriks GJ; Becker ES; van Minnen A
    J Anxiety Disord; 2015 Aug; 34():63-7. PubMed ID: 26121495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of cognitive behavioral therapy with pharmacotherapy.
    Ganasen KA; Ipser JC; Stein DJ
    Psychiatr Clin North Am; 2010 Sep; 33(3):687-99. PubMed ID: 20599140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized controlled trial of the effect of D-cycloserine on exposure therapy for spider fear.
    Guastella AJ; Dadds MR; Lovibond PF; Mitchell P; Richardson R
    J Psychiatr Res; 2007 Sep; 41(6):466-71. PubMed ID: 16828803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.